Overview

Treatment of Advanced Gastrointestinal Cancer in a Phase I/II Trial With Modified Autologous MSC_apceth_101

Status:
Terminated
Trial end date:
2016-09-07
Target enrollment:
Participant gender:
Summary
To evaluate the safety and tolerability of MSC_apceth_101.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Apceth GmbH & Co. KG